We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Pathology

Image Credit: Shutterstock

FDA-Approved Companion Diagnostic Detects PTEN Loss in Prostate Cancer

NeoGenomics has launched the first IHC companion diagnostic test approved by the U.S. FDA for patients with prostate adenocarcinoma.  More...
13 Jul 2026
Image: Overview of the self-supervised learning method DINOv2 applied to digital pathology. (Witowski, J., Zeng, K.G., Cappadona, J. et al. Nature Communication, 2026. https://doi.org/10.1038/s41467-026-73088-y)

New AI Test Delivers Rapid Breast Cancer Recurrence Predictions

An AI test estimates breast cancer recurrence risk from routine slides and data, matching genomic assays and enabling faster care. More...
09 Jul 2026
Image: Primary central nervous system lymphoma (PCNSL) is a rare malignancy of the brain, spinal cord, and eyes that is often diagnosed late and associated with poor outcomes (Photo courtesy of Tdvorak / Wikimedia Commons / CC BY-SA 3.0)

EBV Status Helps Predict Survival in Primary CNS Lymphoma

A new study identifies a three-factor outcome model for immune-related primary CNS lymphoma. More...
07 Jul 2026
Image: Study design using AI-powered analysis of the TME. AI, artificial intelligence; D, day; iTIL, intratumoral TIL; sTIL, stromal TIL; TIL, tumor-infiltrating lymphocyte; TME, tumor microenvironment; WSI, whole-slide image (Derbala MH, et al.  Journal for ImmunoTherapy of Cancer, 2026; https://doi.org/10.1136/jitc-2025-014768)

AI Pathology Tool Predicts Immunotherapy Response in Rare Cancers

An AI approach on pathology slides tracks immune infiltration and tumor content to predict immunotherapy response in rare cancers More...
02 Jul 2026
Image: Melanoma staging relies on sentinel lymph node biopsy, but most procedures are negative, highlighting the need for tools that better estimate lymph node involvement and avoid unnecessary surgery (Image credit: Adobe Stock)

Gene Expression Test Refines Melanoma Biopsy Decision-Making

An integrated 31‑gene expression result better predicts melanoma sentinel lymph node positivity than nomograms. More...
29 Jun 2026
Image: An uncertainty‑aware framework strengthens AI reliability for cancer histology subtyping (Image credit: Shutterstock)

Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping

An uncertainty-aware AI approach boosts pathology, flagging out-of-scope inputs and meeting accuracy targets in cancer subtyping. More...
25 Jun 2026
Image: Biomarker testing is critical for lung cancer therapy selection, yet ordering delays mean biopsy-to-result turnaround still averages about 27 days, according to a new study (image credit: Shutterstock)

Study Highlights Biomarker Testing Delays in Lung Cancer Care

New findings highlight ordering delays as main driver of 27-day biopsy-to-biomarker turnaround, risking delayed targeted therapy. More...
24 Jun 2026
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Automated Coagulation Analyzer
Hemolumi H6


The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
Copyright © 2000-2026 Globetech Media. All rights reserved.